Breast Cancer Clinical Trials

The most recent listing of current clinical trials for breast cancer appears below.

Site: Breast

Protocol ID    Title

ACOSOG-Z11102    Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers (MIBC)

ECOG-2108/RTOG-1173    A Randomized Phase III Trial of the Value of Early Local Therapy for the Intract Primary Tumor in Patients with Metastatic Breast Cancer

GALENA-PRESENT/PH3-01    PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment

IIT-CARDIAC-MRI    Pilot Study to Evaluate Cardiac Function using Cardiac MRI and Dosimetric Correlation in Women Treated for Breast Cancer with Three-Dimensional Conformal Radiation Therapy (3DCRT)

NSABP B-43/RTOG-0974    A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy

NSABP-B-47/RTOG-1272    A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by (Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

NSABP-B-51/RTOG-1304    A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

RTOG-1005    A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost v. Standard Whole Breast Irradiation plus Sequential Boos for Early Stage Breast Cancer

RTOG-1119    Phase II Randomized Study Of Whole Brain Radiotherapy In Combination With Concurrent Lapatinib In Patients With Brain Metastasis From HER 2-Positive Breast Cancer A Collaborative Study Of RTOG And KROG

  Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer